粒子疗法
α粒子
医学物理学
放射性核素治疗
医学
试验药物
放射化学
放射治疗
临床试验
核医学
化学
核物理学
物理
内科学
作者
Bryce Nelson,Jan Andersson,Frank Wuest
出处
期刊:Pharmaceutics
[Multidisciplinary Digital Publishing Institute]
日期:2020-12-31
卷期号:13 (1): 49-49
被引量:53
标识
DOI:10.3390/pharmaceutics13010049
摘要
This review outlines the accomplishments and potential developments of targeted alpha (α) particle therapy (TAT). It discusses the therapeutic advantages of the short and highly ionizing path of α-particle emissions; the ability of TAT to complement and provide superior efficacy over existing forms of radiotherapy; the physical decay properties and radiochemistry of common α-emitters, including 225Ac, 213Bi, 224Ra, 212Pb, 227Th, 223Ra, 211At, and 149Tb; the production techniques and proper handling of α-emitters in a radiopharmacy; recent preclinical developments; ongoing and completed clinical trials; and an outlook on the future of TAT.
科研通智能强力驱动
Strongly Powered by AbleSci AI